bronchiectasis
BRONCHIECTASIS
Bronchiectasis is an irreversible pathologic dilatation or ectasia of the bronchi due to repeated airway infection and inflammation.
It enhances susceptibility to bronchial infection and increases inflammatory reaction which causes further lung damage.
Classic symptoms of of bronchiectasis are cough with chronic sputum production along with recurring infective exacerbations and hemoptysis.
Drug Information

Indication: Upper & lower resp tract, GUT, ENT, skin & soft tissue, bone & joint infections, UTI, O&G infe...

Indication: Lower & upper resp tract, GUT, skin & soft tissue infections. Gonorrhea, acute uncomplicated gonoccal ...

Indication: Ear, nose & throat infections ie, otitis media, sinusitis, tonsillitis & pharyngitis; pneumonia, acute...

Indication: Uncomplicated & complicated infections caused by ciprofloxacin-sensitive pathogens: Infections of the resp...

Indication: Uncomplicated & complicated resp tract infections, otitis media & sinusitis. Eyes, kidneys &/or ef...

Indication: Infections of the resp tract, middle ear, paranasal sinuses, eyes, kidneys &/or efferent urinary tract, ge...

Indication: Resp tract, eye, kidney, urinary tract, genital, GIT, biliary tract, skin & soft tissue, bone & joint ...

Dosage: Adult Severe or complicated UTI, mild to moderate lower resp tract infections, skin & skin structure infec

Indication: Infections of the resp tract, middle ear, paranasal sinuses, eyes, kidneys, urinary tract, GI or biliary tract...

Indication: Short-term treatment of upper & lower resp tract, GUT, skin & soft tissue, bone & joint, & den...

3  /  16
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 28 May 2020
Use of noninvasive ventilation (NIV), similar to invasive mechanical ventilation (IMV), appears to lessen mortality but may increase the risk for transmission of the novel coronavirus disease (COVID-19) in healthcare workers, suggest the results of a study.
Roshini Claire Anthony, 08 May 2020

At present, there are no definitive treatments for COVID-19. More than 300 clinical trials are ongoing in the search for a cure. Some of the treatments being tested were previously used, with varying levels of efficacy, in the treatment of severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS).

Roshini Claire Anthony, 24 Apr 2020

The gap in overall life expectancy between people with HIV (PWH) and those without HIV has narrowed over time, particularly among optimally treated PWH. However, PWH still have fewer comorbidity-free years than those without HIV, according to a study presented at CROI 2020.